FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to methods for improving the biocompatibility of valve and vascular grafts ensured by reducing the immunogenicity and preventing the calcification. The method for improving the biocompatibility of valve and vascular grafts consists in pre-incubation of the tissue grafts in normal saline containing 0.9% sodium chloride, EDTA (0.5-2 mM), organic buffer HEPES (5-20 mM) at pH 7.0 for 4-6 hours, incubation in normal saline containing 0.9% sodium chloride, HEPES 5-20 mM (pH 7.8), 1% sodium deoxycholate for 30-48 h; the tissue grafts are washed from sodium deoxycholate in a solution containing 0.9% sodium chloride, HEPES 5-20 mM (pH 7.8) and 20% ethanol for 8 days with the medium replaced for the fresh one every day and washed from ethanol for one day.
EFFECT: method for improving the biocompatibility enables preventing the graft calcification, reducing their cell toxicity and the immune response to the tissue grafts.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR IMPROVING BIOCOMPATABILITY OF PERICARDIAL BIOMATERIALS FOR RECONSTRUCTIVE SURGERY | 2018 |
|
RU2678966C1 |
METHOD OF PROCESSING GRAFTS FOR CARDIOVASCULAR SURGERY USING SUB- AND SUPERCRITICAL CARBON DIOXIDE | 2022 |
|
RU2796364C1 |
METHOD FOR TREATING CARDIOVASCULAR SURGICAL TRANSPLANTS | 2004 |
|
RU2291675C2 |
METHOD FOR TREATING TRANSPLANTS' TISSUES FOR CARDIOVASCULAR SURGERY | 2002 |
|
RU2231997C2 |
METHOD FOR OBTAINING A BIOENGINEERED GRAFT FOR PLASTY OF AN ANTERIOR ABDOMINAL WALL DEFECT | 2022 |
|
RU2792542C1 |
METHOD OF PRODUCING TISSUE-SPECIFIC MATRIX FOR TISSUE ENGINEERING OF CARTILAGE | 2019 |
|
RU2716577C1 |
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425648C1 |
TREATMENT METHOD OF LIVE FAILURE | 2016 |
|
RU2618989C1 |
METHOD OF TREATING HEPATIC FAILURE | 2015 |
|
RU2586952C1 |
METHOD AND TRANSPLANT FOR TREATMENT OF LIVER FAILURE | 2010 |
|
RU2425647C1 |
Authors
Dates
2013-11-27—Published
2012-09-28—Filed